Altshuler Shaham Ltd - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
Altshuler Shaham Ltd ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$26,174
-56.4%
460
-69.9%
0.00%0.0%
Q3 2022$60,000
-7.7%
1,528
+3.1%
0.00%0.0%
Q2 2022$65,000
+66.7%
1,482
+57.2%
0.00%
Q1 2021$39,000
+2.6%
943
+4.9%
0.00%
-100.0%
Q4 2020$38,000
+58.3%
899
-3.0%
0.00%0.0%
Q3 2020$24,000
-57.9%
927
-56.1%
0.00%
-50.0%
Q2 2020$57,0002,1120.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
TRAN CAPITAL MANAGEMENT, L.P. 1,506,473$61,283,0005.13%
First Light Asset Management, LLC 1,477,496$60,105,0003.96%
SNYDER CAPITAL MANAGEMENT L P 3,427,476$139,430,0003.69%
DOHENY ASSET MANAGEMENT /CA 80,400$3,271,0002.34%
Redwood Investments, LLC 619,766$25,212,0002.11%
HighMark Wealth Management LLC 53,341$2,170,0001.60%
SILVERARC CAPITAL MANAGEMENT, LLC 60,170$2,448,0001.38%
Third Security, LLC 168,604$6,859,0001.33%
Taylor Wealth Management Partners 87,654$3,566,0001.27%
Penn Capital Management Company, LLC 290,394$11,813,0001.19%
View complete list of HALOZYME THERAPEUTICS INC shareholders